Results 11 to 20 of about 41,597 (297)

Direct-acting oral anticoagulants in antiphospholipid syndrome

open access: yesНаучно-практическая ревматология, 2021
Antiphospholipid syndrome is an acquired autoimmune thrombophilia characterized by the development of recurrent vascular thrombosis of any caliber and type or obstetric pathology and the mandatory identification of persistently positive antiphospholipid ...
T. M. Reshetnyak, K. S. Nurbaeva
doaj   +3 more sources

Direct oral anticoagulants and venous thromboembolism [PDF]

open access: yesEuropean Respiratory Review, 2016
Venous thromboembolism (VTE), consisting of deep vein thrombosis and pulmonary embolism, is a major clinical concern associated with significant morbidity and mortality.
Massimo Franchini   +1 more
doaj   +2 more sources

Direct oral anticoagulants. The story of success

open access: yesCardiologia Hungarica
Lets organize a nice funeral for warfarin – told by Eugene Braunwald twenty years ago, when first large scale studies had been planned and started with direct oral anticoagulants (DOACs), earlier called novel oral anticoagulants (NOACS).
Róbert Gábor Kiss
doaj   +2 more sources

Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension

open access: yesClinics, 2018
OBJECTIVES: Chronic thromboembolic pulmonary hypertension is one of the most prevalent forms of pulmonary hypertension and is a major complication of acute pulmonary embolism.
Francisca Alexandra Gavilanes-Oleas   +9 more
doaj   +2 more sources

Direct Oral Anticoagulants: A Quick Guide [PDF]

open access: yesEuropean Cardiology Review, 2017
Vitamin K antagonists, such as warfarin, have been the anticoagulants of choice for many years for patients with AF and other thrombotic conditions. The introduction of direct oral anticoagulants (DOACs) as alternatives represents a major advance in anticoagulation.
Sikorska, Julia, Uprichard, James
openaire   +3 more sources

Direct oral anticoagulants for electrical cardioversion

open access: yesКардиоваскулярная терапия и профилактика, 2021
The article discusses the issues of anticoagulant preparation for elective electrical cardioversion in patients with persistent atrial fibrillation. Updated preparation regimens for electrical cardioversion are proposed, as well as the potential of using
A. N. Volovchenko   +2 more
doaj   +1 more source

Global access to affordable direct oral anticoagulants [PDF]

open access: yes, 2021
Poor control of cardiovascular disease accounts for a substantial proportion of the disease burden in developing countries, but often essential anticoagulant medicines for preventing strokes and embolisms are not widely available.
Magrini, Nicola   +12 more
core   +1 more source

Novel Bleeding Risk Score for Patients with Atrial Fibrillation on Oral Anticoagulants, including Direct Oral Anticoagulants. [PDF]

open access: yes, 2021
OBJECTIVE Balancing bleeding risk and stroke risk in patients with atrial fibrillation (AF) is a common challenge. Though several bleeding risk scores exist, most have not included patients on direct oral anticoagulants (DOAC).
Del Giovane, Cinzia   +26 more
core   +1 more source

Is it necessary to alter anticoagulation therapy for tooth extraction in patients taking direct oral anticoagulants? [PDF]

open access: yes, 2017
PubMedID: 29053656Background: The number of patients using direct oral anticoagulants (DOACs) instead of vitamin K antagonists (VKA) is increasing and there is limited data on the safety of tooth extractions in patients taking DOACs.
Tükel H.-C.   +3 more
core   +2 more sources

Medication non‐adherence as a cause of apixaban failure in venous thromboembolism: The importance of pharmacist medication reconciliation

open access: yesClinical Case Reports, 2022
Venous thromboembolism is often treated with direct oral anticoagulants. In order for direct oral anticoagulants to be effective, patients must adhere to a specific dosing strategy.
Trisha E Jethwa   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy